
ML 154
CAS No. 1345964-89-7
ML 154( NCGC84 )
Catalog No. M27660 CAS No. 1345964-89-7
ML 154 is a potent neuropeptide S receptor (NPSR) antagonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 222 | Get Quote |
![]() ![]() |
10MG | 317 | Get Quote |
![]() ![]() |
25MG | 536 | Get Quote |
![]() ![]() |
50MG | 763 | Get Quote |
![]() ![]() |
100MG | 1053 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameML 154
-
NoteResearch use only, not for human use.
-
Brief DescriptionML 154 is a potent neuropeptide S receptor (NPSR) antagonist.
-
DescriptionML 154 is a potent neuropeptide S receptor (NPSR) antagonist.
-
In VitroWestern Blot Analysis Cell Line:CHO cells expressing NPSR Concentration:0.001 μM, 0.01 μM, 0.1 μM, 1 μM Incubation Time:30 min Result:Exhibited the most potent inhibition on NPS-induced ERK phosphorylation.
-
In VivoAnimal Model:Male Wistar rats (300-350 g) injected with alcohol Dosage:1 mg/kg (10% Solutol, 10% N,N-dimethylacetamide, and 80% 10 mM PBS, pH 7.4) Administration:Intraperitoneal injection; once Result:Inhibited alcohol-induced central ERK phosphorylation in vivo.
-
SynonymsNCGC84
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
RecptorG2019S LRRK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1345964-89-7
-
Formula Weight545.48
-
Molecular FormulaC29H26BrN2PS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (114.58 mM)
-
SMILES[Br-].Cc1c([n+]2ccccc2n1C\C=C\c1ccccc1)P(=S)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Garofalo AW, et al. Selective Inhibitors of G2019S-LRRK2 Kinase Activity. J Med Chem. 2020 Dec 10;63(23):14821-14839.
molnova catalog



related products
-
MK-0557
MK-0557 is a selective and orally available antagonist of the neuropeptide Y5 receptor (Ki: 1.6 nM).
-
SF-22
SF-22 is a neuropeptide Y receptor (Y2R) antagonist that crosses the blood-brain barrier and has potential anti-inflammatory activity for the study of diseases associated with neurological disorders.
-
RFRP-1 (human)
Potent endogenous NPFF receptor agonist (EC50 values are 0.0011 and 29 nM for NPFF2 and NPFF1, respectively). Attenuates contractile function of isolated rat and rabbit cardiac myocytes. Reduces heart rate, stroke volume, ejection fraction and cardiac output, and increases plasma prolactin levels in rats. GnIH homolog.